{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:43:43Z","timestamp":1791146623231,"version":"4.1.0"},"reference-count":60,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\n\t\t\t\t\t<\/jats:bold> Probiotics have been proposed as a treatment for eczema, but the results of intervention trials have been mixed.<\/jats:p><jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> To evaluate the efficacy of probiotics for treating eczema by performing a systematic review of randomized\u2010controlled trials (RCTs).<\/jats:p><jats:p><jats:bold>Design\n\t\t\t\t\t<\/jats:bold> We searched the Cochrane Skin Group Specialised Register, Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, PsycINFO, AMED, LILACS, ISI Web of Science, the reference lists of articles, ongoing clinical trial registers and conference proceedings. RCTs of live orally ingested microorganisms for the treatment of eczema were eligible for inclusion.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> Twelve trials (781 participants) were identified. Meta\u2010analysis of data from five of these trials showed that there was no significant reduction in eczema symptoms with probiotic treatment compared with placebo (mean difference \u22120.90 points on a 20\u2010point visual analogue scale; 95% confidence interval \u22122.84, 1.04). Meta\u2010analysis of data from seven trials showed no significant difference in investigator rated eczema severity between probiotic and placebo treatments. Subgroup analysis by eczema severity or presence of atopy did not identify a specific population in which probiotic treatment was effective. There was significant heterogeneity between studies; however, the results of three studies that used the same probiotic strain were concordant. The adverse events search identified case reports of sepsis and bowel ischaemia caused by probiotics.<\/jats:p><jats:p><jats:bold>Conclusions\n\t\t\t\t\t<\/jats:bold> Currently, probiotics cannot be recommended for treating eczema. The heterogeneity between studies may be attributable to probiotic strain\u2010specific effects, which means that novel probiotic strains may still have a role in eczema management.<\/jats:p>","DOI":"10.1111\/j.1365-2222.2009.03305.x","type":"journal-article","created":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T09:18:24Z","timestamp":1246439904000},"page":"1117-1127","source":"Crossref","is-referenced-by-count":95,"title":["Probiotics for the treatment of eczema: a systematic review"],"prefix":"10.1111","volume":"39","author":[{"given":"R. J.","family":"Boyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. J.","family":"Bath\u2010Hextall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Leonardi\u2010Bee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. F.","family":"Murrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L\u2010K","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,7,9]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70536-1"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.3109\/9780203908877-3"},{"key":"e_1_2_6_4_2","first-page":"159","article-title":"Atopic eczema","volume":"76","author":"Su JC","year":"1997","journal-title":"its impact on the family and financial cost"},{"key":"e_1_2_6_5_2","first-page":"229","article-title":"Atopic eczema","volume":"35","author":"Kemp AS.","year":"1999","journal-title":"its social and financial costs"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120528"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta4370"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.118130"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.111237"},{"key":"e_1_2_6_10_2","first-page":"741","article-title":"Fecal microbiota in sensitized wheezy and non\u2010sensitized non\u2010wheezy children","volume":"35","author":"Murray CS","year":"2005","journal-title":"a nested case-control study"},{"key":"e_1_2_6_11_2","first-page":"661","article-title":"Gut microbiota composition and development of atopic manifestations in infancy","volume":"56","author":"Penders J","year":"2007","journal-title":"the KOALA Birth Cohort Study"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.09.011"},{"key":"e_1_2_6_13_2","volume-title":"Guidelines for the evaluation of probiotics in food","author":"FAO\/WHO.","year":"2002"},{"key":"e_1_2_6_14_2","first-page":"CD003048","article-title":"Probiotics for treating infectious diarrhoea","volume":"4","author":"Allen SJ","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_15_2","first-page":"305","article-title":"Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis","volume":"119","author":"Gionchetti P","year":"2000","journal-title":"a double-blind, placebo-controlled trial"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2000.00948.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.06.068"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/08910609309141340"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1600663"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.1.171"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470712184"},{"issue":"4","key":"e_1_2_6_22_2","first-page":"CD006135","article-title":"Probiotics for treating eczema","author":"Boyle RJ","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.389"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01543.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2006.02485.x"},{"key":"e_1_2_6_26_2","first-page":"892","article-title":"Effects of probiotics on atopic dermatitis","volume":"90","author":"Weston S","year":"2005","journal-title":"a randomised controlled trial"},{"key":"e_1_2_6_27_2","first-page":"10","article-title":"Clinical validation and guidelines for the SCORAD index","volume":"195","author":"Kunz B","year":"1997","journal-title":"consensus report of the European Task Force on Atopic Dermatitis"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07558.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2000.00943.x"},{"key":"e_1_2_6_30_2","first-page":"899","article-title":"No effects of probiotics on atopic dermatitis in infancy","volume":"36","author":"Brouwer ML","year":"2006","journal-title":"a randomized placebo-controlled trial"},{"key":"e_1_2_6_31_2","first-page":"20","article-title":"Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis","volume":"52","author":"Hattori K","year":"2003","journal-title":"Arerugi"},{"key":"e_1_2_6_32_2","first-page":"223","article-title":"Probiotic bacteria in the management of atopic disease","volume":"36","author":"Kirjavainen PV","year":"2003","journal-title":"underscoring the importance of viability"},{"key":"e_1_2_6_33_2","first-page":"179","article-title":"Probiotics","volume":"99","author":"Majamaa H","year":"1997","journal-title":"a novel approach in the management of food allergy"},{"key":"e_1_2_6_34_2","first-page":"431","article-title":"Prebiotics and synbiotics","volume":"61","author":"Passeron T","year":"2006","journal-title":"two promising approaches for the treatment of atopic dermatitis in children above 2 years"},{"key":"e_1_2_6_35_2","first-page":"494","article-title":"Probiotics in the treatment of atopic eczema\/dermatitis syndrome in infants","volume":"60","author":"Viljanen M","year":"2005","journal-title":"a double-blind placebo-controlled trial"},{"key":"e_1_2_6_36_2","volume-title":"Review Manager [RevMan] version 5.0","author":"The Cochrane Collaboration.","year":"2008"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_2_6_38_2","first-page":"CD006135","article-title":"Probiotics for atopic eczema (Protocol)","author":"Boyle RJ","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1179\/acb.2004.033"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000154588.79356.e6"},{"key":"e_1_2_6_41_2","first-page":"2531","article-title":"Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities","volume":"128","author":"Lestin F","year":"2003","journal-title":"Dtsch Med Wochenschr"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200301000-00013"},{"key":"e_1_2_6_43_2","first-page":"1256","article-title":"Probiotic use in clinical practice","volume":"83","author":"Boyle RJ","year":"2006","journal-title":"what are the risks?"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/73.2.465s"},{"key":"e_1_2_6_45_2","first-page":"651","article-title":"Probiotic prophylaxis in predicted severe acute pancreatitis","volume":"371","author":"Besselink MG","year":"2008","journal-title":"a randomised, double-blind, placebo-controlled trial"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1159\/000080855"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.10.043"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.07.042"},{"key":"e_1_2_6_49_2","first-page":"508","article-title":"Efficacy of probiotics in the treatment of pediatric atopic dermatitis","volume":"101","author":"Michail SK","year":"2008","journal-title":"a meta-analysis of randomized controlled trials"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07496.x"},{"key":"e_1_2_6_51_2","first-page":"782","article-title":"Cochrane reviews compared with industry supported meta\u2010analyses and other meta\u2010analyses of the same drugs","volume":"333","author":"Jorgensen AW","year":"2006","journal-title":"systematic review"},{"key":"e_1_2_6_52_2","first-page":"CD005496","article-title":"Probiotics for prevention of necrotizing enterocolitis in preterm infants","author":"Alfaleh K","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1097\/00130832-200410000-00009"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.78.3.230"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni1018"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5484.1560"},{"key":"e_1_2_6_57_2","first-page":"1174","article-title":"Probiotics in prevention of IgE\u2010associated eczema","volume":"119","author":"Abrahamsson TR","year":"2007","journal-title":"a double-blind, randomized, placebo-controlled trial"},{"key":"e_1_2_6_58_2","first-page":"192","article-title":"Probiotics and prebiotic galacto\u2010oligosaccharides in the prevention of allergic diseases","volume":"119","author":"Kukkonen K","year":"2007","journal-title":"a randomized, double-blind, placebo-controlled trial"},{"key":"e_1_2_6_59_2","first-page":"CD006475","article-title":"Probiotics in infants for prevention of allergic disease and food hypersensitivity","author":"Osborn DA","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_60_2","first-page":"e850","article-title":"Randomized, double\u2010blind, placebo\u2010controlled trial of probiotics for primary prevention","volume":"121","author":"Kopp MV","year":"2008","journal-title":"no clinical effects of Lactobacillus GG supplementation"},{"key":"e_1_2_6_61_2","first-page":"184","article-title":"Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high\u2010risk children","volume":"119","author":"Taylor AL","year":"2007","journal-title":"a randomized controlled trial"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2009.03305.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2009.03305.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T21:20:27Z","timestamp":1697404827000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2009.03305.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,9]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1111\/j.1365-2222.2009.03305.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2009.03305.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,9]]}}}